Gastroesophageal reflux disease

There are 98 papers on gastroesophageal reflux disease in aging research: 4 trials and 68 observational studies in people, 24 reviews. The newest story, Oct 30, 2026: “Physical activity’s links to death risk differed by sex”.

Disease

98 papers study it20 more mention it47 findings

10 new papers in 30 daysSee all 118 papers on gastroesophageal reflux disease

At a glance

Gastroesophageal reflux disease is linked with frailty, shorter leukocyte telomeres and higher neurodegenerative disease risk in human cohorts. GLP-1 receptor agonist use is linked with higher reflux risk in people with diabetes and obesity but lower risk after bariatric surgery. A human trial reports less reflux with Nissen sleeve gastrectomy than standard sleeve gastrectomy.

47 findings in 33 papers from 2016 to 2026, 8 of them since July 2026

“clinical GERD incidence 57.9% versus 18.8% (effect size: .23 [.07; .73], P = .01) for the SG and NSG groups, respectively.”
Five-year comparative outcomes of Nissen sleeve gastrectomy versus standard sleeve gastrectomy in patients with type 2 diabetesSurgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery2026doi:10.1016/j.soard.2026.02.009
  • Human trial4
  • Humans68
  • In silico1

Interventions

5

Roux-en-y gastric bypass

downin humans2

2 studies
  1. Roux-en-y gastric bypass is linked with lower gastroesophageal reflux disease in humans among individuals with baseline GERD (70.0% vs 21.9%).

    “among individuals with baseline GERD, RYGB achieved higher GERD remission rates at 12 months (70.0% vs 21.9%).”

    Humansamong individuals with baseline GERD12 months

    Five-Year Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: A Comparative Study of Weight Loss and Nutritional Deficiencies

    Research SquarePreprint

  2. Roux-en-y gastric bypass is linked with lower gastroesophageal reflux disease in humans (revisional surgery after sleeve gastrectomy) (95 vs. 5%, p = 0.02).

    “RYGB yielded markedly better GERD resolution (95 vs. 5%, p = 0.02)”

    Humansrevisional surgery after sleeve gastrectomy7 yearsn = 105

    Comparative seven year outcomes of RYGB and SADI-S as revisional procedures for weight recurrence regain after sleeve gastrectomy: weight loss trajectory, reflux control, and metabolic safety

    Surgical endoscopy

More on Roux-en-y gastric bypass

Statins

no changein humans1OR 0.999

1 study
  1. Statins were not clearly linked with gastroesophageal reflux disease in humans (Genetically proxied through HMGCR-mediated LDL-C reduction) (OR 0.999, 95% CI 0.992–1.006).

    “No significant causal association was found between statin use and gastroesophageal reflux disease (OR = 0.999, 95% CI: 0.992-1.006, p = 0.773).”

    HumansGenetically proxied through HMGCR-mediated LDL-C reductionn = 462,933

    Mendelian Randomization-Based Analysis of Causal Effects Between Statins and Common Upper Gastrointestinal Diseases

    Gastroenterology research and practice

More on Statins

Alcohol

no changein humans1HR 1

1 study
  1. Alcohol was not clearly linked with gastroesophageal reflux disease in humans (Without GERD at baseline) (HR 1.00 (95% CI 0.98–1.03)).

    “Each healthy lifestyle, except for moderate alcohol intake (hazard ratios [HR], 1.00; 95% confidence interval [CI]: 0.98-1.03) was associated with a lower risk of GERD.”

    HumansWithout GERD at baselineModerate intakeMean follow-up of 12.7 yearsn = 306,543

    Healthy lifestyle as a protective factor against the risk of gastroesophageal reflux disease: Prospective population cohort analysis

    PloS one

More on Alcohol

Antireflux surgery

no changein humans1

1 study
  1. Antireflux surgery showed no clear effect on gastroesophageal reflux disease in humans (addition of antireflux procedures to MBS).

    “addition of antireflux procedures to MBS did not improve GERD outcome.”

    Reviewaddition of antireflux procedures to MBS

    Effects of bariatric surgery on obesity associated gastroesophageal reflux disease: Insights from a systematic review and network meta-analysis

    World journal of gastroenterology

More on Antireflux surgery

Sleeve gastrectomy with transit bipartition

downin humans1OR 6.9

1 study
  1. Sleeve gastrectomy with transit bipartition decreases gastroesophageal reflux disease in humans (OR = 6.90, CI 1.98–24.09).

    “SG-TB demonstrated significantly higher GERD remission rates versus SG (OR = 6.90, CI 1.98–24.09).”

    Review

    Efficacy and safety of single-anastomosis gastric bypass variants versus sleeve gastrectomy or Roux-en-Y gastric bypass: a systematic review and meta-analysis

    Updates in surgery

More on Sleeve gastrectomy with transit bipartition

Effects

1

Frailty

mediatesin humans1

1 study
  1. Gastroesophageal reflux disease is linked with frailty in humans (mediating depression and frailty) (72.5%).

    “while GERD mediated 72.5% of the association between depression and frailty (P < .001).”

    Humansmediating depression and frailty

    The mediating role of dietary habits in the causal relationships between frailty, depression, and gastroesophageal reflux disease

    Medicine

Upstream

4

GLP1R

no changein humans1OR 0.97

1 study
  1. GLP1R was not clearly linked with gastroesophageal reflux disease in humans (OR 0.97, 95% CI 0.85-1.11).

    “Genetically proxied GLP-1 receptor expression was not associated with reflux disease (odds ratio 0.97, 95% confidence interval 0.85-1.11)”

    Humansgenetically proxied expression (cis-eQTL drug-target Mendelian randomization); replicated in FinnGen R12n = 31,684

    Genetic Assessment of Oesophageal Safety of GLP-1 and GIP Receptor Perturbation: A Drug-Target Mendelian Randomisation Study

    Biomedicines

More on GLP1R

Body mass index

mediatesin humans1

1 study
  1. Body mass index is linked with gastroesophageal reflux disease in humans (mediation of DI-GM and GERD association) (proportion mediated 21.43%).

    “BMI (proportion mediated 21.43%) and phenotypic age acceleration (7.53%) both significantly mediated the association (both P < 0.001).”

    Humansmediation of DI-GM and GERD association13.6 yearsn = 133,915

    Dietary index for gut microbiota and risk of incident gastroesophageal reflux disease: a prospective cohort analysis integrating plasma proteomics in the UK Biobank

    Frontiers in nutrition

More on Body mass index

PhenoAge

mediatesin humans1

1 study
  1. PhenoAge is linked with gastroesophageal reflux disease in humans (mediation of DI-GM and GERD association) (proportion mediated 7.53%).

    “phenotypic age acceleration (7.53%) both significantly mediated the association (both P < 0.001).”

    Humansmediation of DI-GM and GERD association13.6 yearsn = 133,915

    Dietary index for gut microbiota and risk of incident gastroesophageal reflux disease: a prospective cohort analysis integrating plasma proteomics in the UK Biobank

    Frontiers in nutrition

More on PhenoAge

Time since surgery

upin humans1

1 study
  1. time since surgery is linked with higher gastroesophageal reflux disease in humans (post-LSG during Ramadan).

    “GERD prevalence increased over time, particularly in the ≥12 months group, while vomiting and dumping syndromes remained stable.”

    Humanspost-LSG during Ramadann = 100

    Navigating Ramadan Fasting Following Laparoscopic Sleeve Gastrectomy: Clinical Insights and Patient Experiences

    Cureus

Associations

30

GLP-1 receptor agonists

upin humans3downin humans1RR 0.645

4 studies
  1. GLP-1 receptor agonists are associated with gastroesophageal reflux disease in humans (ROR 2.83 (95% CI 2.39 to 3.35) in FAERS; JADER 4.76; Canada Vigilance 2.91).

    “significant GERD signals were detected across all databases: FAERS (ROR, 2.83; 95% CI, 2.39 to 3.35; 9,245 vs 139)”

    Humans

    Multi-Database Pharmacovigilance Analysis of Gastroesophageal Reflux Disease Associated with GLP-1 Receptor Agonists: A Cross-National Signal Validation Study

    Gut and liver

  2. GLP-1 receptor agonists are linked with a higher risk of gastroesophageal reflux disease in humans (patients with diabetes mellitus and obesity, propensity-matched against controls).

    “GERD (HR 1.18 [1.14, 1.22])”

    Humanspatients with diabetes mellitus and obesity, propensity-matched against controls1 yearn = 164,987

    Incidence of Gastrointestinal Adverse Events and Healthcare Resource Utilization in Patients Using Glucagon-Like Peptide-1 Analogs: A Real-World Study

    Digestive diseases and sciences

  3. GLP-1 receptor agonists are linked with a lower risk of gastroesophageal reflux disease in humans (postoperative use versus non-use after bariatric surgery) (RR 0.645 (95% CI 0.539-0.773)).

    “GERD (RR 0.645; 95% CI: 0.539-0.773; p<0.001)”

    Humanspostoperative use versus non-use after bariatric surgeryfive yearsn = 6,571

    MON-690 Impact of GLP-1 Receptor Agonists on Late Complications Following Bariatric Surgery

    ENDO 2025 abstract

  4. GLP-1 receptor agonists are associated with gastroesophageal reflux disease in humans (spontaneous reports in FAERS database).

    “This was followed by GERD which also had very high signal ratios and was significant in all drugs assessed.”

    Humansspontaneous reports in FAERS database

    Otolaryngologic Side Effects of GLP-1 Receptor Agonists

    The Laryngoscope

More on GLP-1 receptor agonists

Frailty

upin humans3upin silico1HR 1.6

4 studies
  1. Gastroesophageal reflux disease is associated with frailty in humans (COPD; independent of FEV1).

    “frailty was associated with social factors (living alone, unemployment), comorbidities (CVD, gastro-oesophageal reflux disease)”

    HumansCOPD; independent of FEV1n = 225

    Frailty and social, clinical and computed tomography imaging factors in COPD: a multicentre study

    ERJ open research

  2. Frailty is associated with gastroesophageal reflux disease in humans.

    “We identified significant bidirectional causal relationships between frailty and GERD, frailty and depression, and depression and GERD.”

    Humans

    The mediating role of dietary habits in the causal relationships between frailty, depression, and gastroesophageal reflux disease

    Medicine

  3. Frailty is linked with a higher risk of gastroesophageal reflux disease in humans (HR = 1.60, 95% CI 1.52-1.68).

    “pre-frail (hazard ratios [HR] = 1.21, 95% confidence interval [CI] 1.18-1.24) and frail (HR = 1.60, 95% CI 1.52-1.68) participants had significantly higher risks of GERD.”

    Humansmedian of 13.5-yearsn = 327,965

    Pre-frailty is associated with higher risk of gastroesophageal reflux disease: a large prospective cohort study

    Scientific reports

  4. Gastroesophageal reflux disease is associated with frailty in silico.

    “Our research provided strong evidence of genetic correlation between GERD and several age-related phenotypes, especially frailty index (FI) and telomere length (TL)”

    In silico

    Shared genetic architecture of gastroesophageal reflux disease and age related phenotypes

    Scientific reports

Incretin drugs

upin humans1

1 study
  1. Incretin drugs are associated with gastroesophageal reflux disease in humans.

    “Novel incretin drugs’ use can be associated, especially in the short period, with GERD.”

    Reviewespecially in the short period

    GERD AND OBESITY

    Best practice & research. Clinical gastroenterology

More on Incretin drugs

Obesity

upin humans1

1 study
  1. Obesity is associated with gastroesophageal reflux disease in humans.

    “obesity and central adiposity are associated with GERD.”

    Review

    GERD AND OBESITY

    Best practice & research. Clinical gastroenterology

More on Obesity

Healthy lifestyle

downin humans1HR 0.63

1 study
  1. Healthy lifestyle is associated with gastroesophageal reflux disease in humans (Without GERD at baseline) (HR 0.63 (95% CI 0.60–0.66), score 5–7 versus less than 2; P for trend <0.001).

    “those with 2, 3, 4, and 5-7 of this score showed a significantly lower risk of GERD”

    HumansWithout GERD at baselineHealthy lifestyle score 5–7 versus less than 2Mean follow-up of 12.7 yearsn = 306,543

    Healthy lifestyle as a protective factor against the risk of gastroesophageal reflux disease: Prospective population cohort analysis

    PloS one

More on Healthy lifestyle

Bladder cancer

upin silico1OR 1.254

1 study
  1. Gastroesophageal reflux disease is associated with bladder cancer in silico (two-sample Mendelian randomization meta-analysis) (OR 1.254, 95% CI 1.047-1.501).

    “Suggestive positive associations were also observed for laryngeal cancer (OR = 1.774; 95% CI: 1.091-2.884; P = .021) and bladder cancer (OR = 1.254; 95% CI: 1.047-1.501; P = .014)”

    In silicotwo-sample Mendelian randomization meta-analysis

    Genetic evidence for associations between gastroesophageal reflux disease and site-specific extraesophageal cancers: A Mendelian randomization study

    Medicine

More on Bladder cancer

Laryngeal cancer

upin silico1OR 1.774

1 study
  1. Gastroesophageal reflux disease is associated with laryngeal cancer in silico (two-sample Mendelian randomization meta-analysis) (OR 1.774, 95% CI 1.091-2.884).

    “Suggestive positive associations were also observed for laryngeal cancer (OR = 1.774; 95% CI: 1.091-2.884; P = .021) and bladder cancer (OR = 1.254; 95% CI: 1.047-1.501; P = .014)”

    In silicotwo-sample Mendelian randomization meta-analysis

    Genetic evidence for associations between gastroesophageal reflux disease and site-specific extraesophageal cancers: A Mendelian randomization study

    Medicine

More on Laryngeal cancer

Lung cancer

upin silico1OR 1.19

1 study
  1. Gastroesophageal reflux disease raises the risk of lung cancer in silico (OR 1.190, 95% CI 1.040-1.362).

    “In Multivariable Mendelian randomization analyses accounting for body mass index, smoking intensity, and alcohol consumption, the association with lung cancer remained statistically significant (OR = 1.190; 95% CI: 1.040-1.362; P = .012)”

    In silicomultivariable Mendelian randomization accounting for body mass index, smoking intensity, and alcohol consumption

    Genetic evidence for associations between gastroesophageal reflux disease and site-specific extraesophageal cancers: A Mendelian randomization study

    Medicine

More on Lung cancer

Exenatide

downin humans1

1 study
  1. Exenatide is associated with gastroesophageal reflux disease in humans (FAERS) (ROR 0.60 (95% CI 0.46 to 0.77)).

    “Exenatide showed an inverse association in FAERS (ROR, 0.60; 95% CI, 0.46 to 0.77).”

    HumansFAERS

    Multi-Database Pharmacovigilance Analysis of Gastroesophageal Reflux Disease Associated with GLP-1 Receptor Agonists: A Cross-National Signal Validation Study

    Gut and liver

More on Exenatide

Semaglutide

upin humans1

1 study
  1. Semaglutide is associated with gastroesophageal reflux disease in humans (versus dipeptidyl peptidase-4 inhibitors) (ROR 3.44 to 6.93 across databases).

    “Drug-specific analyses revealed the strongest signals for semaglutide across all databases (3.44 to 6.93)”

    Humansversus dipeptidyl peptidase-4 inhibitors

    Multi-Database Pharmacovigilance Analysis of Gastroesophageal Reflux Disease Associated with GLP-1 Receptor Agonists: A Cross-National Signal Validation Study

    Gut and liver

More on Semaglutide

Nissen sleeve gastrectomy

downin humans1

1 study
  1. Nissen sleeve gastrectomy lowers the risk of gastroesophageal reflux disease in humans (versus standard sleeve gastrectomy) (18.8% vs 57.9% (effect size: .23 [.07; .73], P = .01)).

    “clinical GERD incidence 57.9% versus 18.8% (effect size: .23 [.07; .73], P = .01) for the SG and NSG groups, respectively.”

    Human trialversus standard sleeve gastrectomy5 yearsn = 82

    Five-year comparative outcomes of Nissen sleeve gastrectomy versus standard sleeve gastrectomy in patients with type 2 diabetes

    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

More on Nissen sleeve gastrectomy

All 30

Trial sponsors

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Gastroesophageal reflux disease is linked with frailty and neurodegenerative disease in human cohorts, while shorter leukocyte telomeres are associated with greater reflux risk. GLP-1 receptor agonist associations point both ways: higher risk in people with diabetes and obesity, but lower risk after bariatric surgery. A human trial reports lower reflux risk after Nissen sleeve than standard sleeve gastrectomy.

  2. Summary rewritten as its findings changed.

    As it read before

    An in silico Mendelian randomization study links gastroesophageal reflux disease to higher lung cancer risk after accounting for body mass index, smoking intensity and alcohol consumption, and to bladder and laryngeal cancers.

  3. GERD AND OBESITY · 2 findings

  4. Summary written from the findings.

Latest

Dec 2025: 2Jan 2026: 5Feb 2026: 8Mar 2026: 9Apr 2026: 0May 2026: 5Jun 2026: 3Jul 2026: 5Aug 2026: 2Sep 2026: 2Oct 2026: 7Nov 2026: 654 papers in 12 months
Frontiers in Public Health

Physical activity’s links to death risk differed by sex

Median male-to-female activity-duration ratios were 0.90 for death from any cause, 1.37 for heart and blood vessel disease deaths, and 0.71 for cancer deaths.Median male-to-female activity-duration ratios were 0.90 for death from any cause, 1.37 for heart and blood vessel disease deaths, and 0.71 for cancer deaths.

Cohort · 86,196 peoplePopulations

See all 118 papers on gastroesophageal reflux disease